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Purpose: This study tested the effectiveness of moxibus-
tion on pain and function in chronic knee osteoarthritis (KOA),
and evaluated safety.
Methods: Amulti-centre, non-blinded, parallel-group, ran-
domised controlled trial compared moxibustion with usual
care (UC) in KOA. 212 South Korean patients aged 40-70 were
recruited from 2011-12, stratiﬁed by mild (Kellgren/Lawrence
scale grades 0/1) andmoderate-severe KOA (grades 2/3/4), and
randomly allocated tomoxibustion or UC for four weeks. Mox-
ibustion involved burning mugwort devices over acupuncture
and Ashi points in affected knee(s). UC was allowed. Korean
Western Ontario and McMaster Universities Questionnaire
(K-WOMAC), Short Form 36 Health Survey (SF-36 v2), Beck
Depression Inventory (BDI), physical performance test, pain
numeric rating scale (NRS) and adverse events were evaluated
at 5 and 13 weeks. K-WOMAC global score at 5 weeks was the
primary outcome.
Results: 102 patients (73 mild, 29 moderate-severe) were
allocated tomoxibustion, 110 (77mild, 33moderate-severe) to
UC. K-WOMAC global score (moxibustion 25.42 +/-SD 19.26,
UC 33.60+/-17.91, p<0.01, effect size = 0.0477), NRS (moxi-
bustion 44.77+/-22.73, UC 56.23+/-17.71, p<0.01, effect size =
0.0073) and timed-stand test (moxibustion 24.79+/-9.7 6, UC
25.24+/-8.84, p=0.0486, effect size = 0.0021) were improved by
moxibustion at 5 weeks. The primary outcome improved for
mild but not moderate-severe KOA. At 13 weeks, moxibus-
tion signiﬁcantly improved the K-WOMAC global score and
NRS. Moxibustion improved SF-36 physical component sum-
mary (p=0.0299), bodily pain (p=0.0003), physical functioning
(p=0.0025) and social functioning (p=0.0418) at 5 weeks, with
no difference in mental component summary at 5 and 13
weeks. BDI showed no difference (p=0.34) at 5 weeks. After
1158 moxibustion treatments, 121 adverse events included
ﬁrst (n=6) and second degree (n=113) burns, pruritus and
fatigue (n=2).
Conclusion: Conclusions: Moxibustion may improve pain,
function and quality of life in KOApatients, but adverse events
are common. Limitations included no sham control or blind-
ing.
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Purpose: We aimed to investigate whether effects of
acupuncture vary with age in chronic pain patients≥ 60 years.
Methods: We included individual patient level data from
the database of the Acupuncture Trialists Collaboration
(patients aged ≥ 60 years, intervention period ≥ two months).
A multivariate regression model predicting standardized
pain outcome measures after the intervention (two or three
months) andafter sixmonthswereﬁtted to thedata, analyzing
acupuncture vs. no acupuncture and vs. sham acupuncture.
Results:We included 5438 patients (2415 acupuncture, 2141
no acupuncture, 882 sham acupuncture) from 25 trials. Pain
after treatment was similar in patients undergoing acupunc-
ture, irrespective of age (regression coefﬁcient b=0.03 standard
deviations of pain per 10 years of age, P=0.5). Findings were
similar for patients in no acupuncture control groups (b=0.02,
P =0.6). Patients receiving sham acupuncture reported more
pain with increasing age (b=0.23, P<0.01; P-values for the dif-
ferences in increase: acupuncture vs. no acupuncture, P=0.9;
acupuncture vs. sham, P=0.01). Results were similar at six
months, but did not reach statistical signiﬁcance.
Conclusion: The results indicate that in patients ≥ 60 years
of age there is a treatment-age-interaction with the effect
of sham acupuncture decreasing and the difference between
true and sham acupuncture increasing with age.
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